Business Standard

ICICI Venture to sell Vetnex stake to Pfizer for Rs 200 cr

Related News

today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

Vetnex Animal Health is a part of RFCL, a significant stake in which was acquired by ICICI Venture from Ranbaxy Laboratories for Rs 125 crore in 2005.

Though ICICI Venture did not disclose much, sources said the deal was worth over Rs 200 crore and that Vetnex had an annual turnover of Rs 100-120 crore. French animal healthcare majors Virbac and Sanofi-Aventis were also in the race, they said. When contacted, RFCL executives declined to comment.

Vetnex is a market leader in poultry, livestock and pet healthcare and is one of the top three players in the Indian animal healthcare market. The company is valued at about Rs 1,400 crore.

RFCL, which operates in chemicals, diagnostics and animal healthcare sectors, had de-merged its animal health division into Vetnex earlier this year.

Read more on:   
|

ICICI Venture to sell Vetnex stake to Pfizer for Rs 200 cr

ICICI Venture today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to Pfizer Animal Health of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

ICICI Venture today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to Pfizer Animal Health of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

Vetnex Animal Health is a part of RFCL, a significant stake in which was acquired by ICICI Venture from Ranbaxy Laboratories for Rs 125 crore in 2005.

Though ICICI Venture did not disclose much, sources said the deal was worth over Rs 200 crore and that Vetnex had an annual turnover of Rs 100-120 crore. French animal healthcare majors Virbac and Sanofi-Aventis were also in the race, they said. When contacted, RFCL executives declined to comment.

Vetnex is a market leader in poultry, livestock and pet healthcare and is one of the top three players in the Indian animal healthcare market. The company is valued at about Rs 1,400 crore.

RFCL, which operates in chemicals, diagnostics and animal healthcare sectors, had de-merged its animal health division into Vetnex earlier this year.

image

Read More

Sensex ends at 3-week low; sentiment still weak

The Sensex fell to a three-week low on Monday after disappointing quarterly earnings hit Bank of Baroda and IDFC, while investors continued to book ...

Recommended for you

Advertisements

Quick Links

Market News

Delivery-based volumes hit one-year high in March

Earlier, in March 2014, more than half, or 51%, of the total traded shares got converted into delivery before the general elections

Gold shipments into Gujarat register highest rise in last four years: GSECL

The official added that rise in import of gold is a sign that the economy is recovering slowly

FY16 begins on a firm note; Sensex ends 300 points higher

The 30-share Sensex gained 303 points to end at 28,260 and the 50-share Nifty soared 95 points to close at 8,586

Sensex gains over 300 points led by financials

Provisionally, the 30-share Sensex gained 134 points to end at 28,091 and the 50-share Nifty soared 39 points to close at 8,530

Bank Nifty rebounds over 450 points from intra-day low

At 1506 hours, Bank Nifty was up 386 points at 18,592, bouncing back 461 points from intra-day low of 18,131 on the NSE.

 

Back to Top